Authors
Loading...
Beta-blocker use was associated with improved survival at lower doses in real-world HF patients; extends trial findings to older comorbid cohorts but remains hypothesis-generating.
Key points are not available for this paper at this time.
Tandon et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: